Too much to do Imho bubs so unlikely imho. I also am braced for the profit numbers. I have no evidence but because of all the good news in terms of approvals, launch and sales I am sensing that MVP margins may be quite thin. Particularly as they've signed some quality partners and I'm sure these don't come cheap. They'd drive some pretty hard commissions imho. Also not sure whether the plant is completed and on budget. Much silence in this regard.
Ann: Penthrox replaces Nitrous Oxide in New Zealand Ambulance, page-17
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
-0.015(3.57%) |
Mkt cap ! $45.62M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 43.5¢ | 40.5¢ | $57.24K | 137.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11372 | 40.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.0¢ | 8392 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| MVP (ASX) Chart |